Long-term survival following additive radiotherapy in patients with atypical teratoid rhabdoid tumors

2016 ◽  
Vol 192 (8) ◽  
pp. 569-581 ◽  
Author(s):  
Khaled Elsayad ◽  
Jan Kriz ◽  
Laith Samhouri ◽  
Uwe Haverkamp ◽  
Ronald Straeter ◽  
...  
2019 ◽  
Vol 36 (4) ◽  
pp. 713-719
Author(s):  
Alexandra Richards ◽  
Ronak Ved ◽  
Christopher Murphy ◽  
Dawn Hennigan ◽  
John-Paul Kilday ◽  
...  

Abstract Purpose To evaluate overall survival for atypical teratoid rhabdoid tumors (ATRTs) in relation to extent of surgical resection. Methods The neurosurgical tumor databases from three UK Pediatric centers (University Hospital of Wales, Alder Hey and Royal Manchester Children’s Hospital) were analyzed. Patients with a diagnosis of ATRT were identified between 2000 and 2018. Data was collected regarding demographics, extent of resection, complications, and overall survival. Results Twenty-four patients diagnosed with ATRT underwent thirty-eight operations. The age range was 20 days to 147 months (median 17.5 months). The most common location for the tumor was the posterior fossa (nine patients; 38%). Six patients (25%) underwent a complete total resection (CTR), seven (29%) underwent a near total resection (NTR), eight (33.3%) underwent a subtotal resection (STR), and three patients (12.5%) had biopsy only. Two-thirds of patients who underwent a CTR are still alive, as of March 2019, compared to 29% in the NTR and 12.5% in the STR groups. Out of the thirty-eight operations, there were a total of twenty-two complications, of which the most common was pseudomeningocele (27%). The extent of surgical resection (p = 0.021), age at surgery (p = 0.00015), and the presence of metastases at diagnosis (0.015) significantly affected overall survival. Conclusions Although these patients are a highly vulnerable group, maximal resection is recommended where possible, for the best chance of long-term survival. However, near total resections are likely beneficial when compared with subtotal resections and biopsy alone. Maximal surgical resection should be combined with adjuvant therapies for the best long-term outcomes.


2015 ◽  
Vol 31 (8) ◽  
pp. 1393-1399 ◽  
Author(s):  
Vivek Verma ◽  
Catrina P. Johnson ◽  
Nathan R. Bennion ◽  
Abhijeet R. Bhirud ◽  
Sicong Li ◽  
...  

2015 ◽  
Vol 62 (7) ◽  
pp. 1265-1269 ◽  
Author(s):  
Lucie Lafay-Cousin ◽  
Taryn Fay-McClymont ◽  
Donna Johnston ◽  
Chris Fryer ◽  
Katrin Scheinemann ◽  
...  

BMC Cancer ◽  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Piergiorgio Modena ◽  
Iacopo Sardi ◽  
Monica Brenca ◽  
Laura Giunti ◽  
Anna Maria Buccoliero ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Fahd Refai ◽  
Haneen Al-Maghrabi ◽  
Hassan Al Trabolsi ◽  
Jaudah Al-Maghrabi

Atypical teratoid rhabdoid tumors (ATRTs) are rare and aggressive central nervous system tumors that infrequently arise in spinal locations in young children. Provided clinical and diagnostic suspicion is high, the histopathological diagnosis is relatively straightforward to secure by testing for the characteristic loss of the tumor suppressor protein SMARCB1/INI1. Here, we describe a case of thoracic spinal ATRT in a three-year-old boy that showed characteristic aggressive progression until managed with intensive multimodal therapy to achieve durable long-term remission. In doing so, we review the histopathological features, management, and current advances in molecular biology that hold promise for personalized ATRT therapy.


Sign in / Sign up

Export Citation Format

Share Document